High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy
about
Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV ExposuresHIV Risk Behaviors, Perceptions, and Testing and Preexposure Prophylaxis (PrEP) Awareness/Use in Grindr-Using Men Who Have Sex With Men in Atlanta, GeorgiaCorrelates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryExploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study.Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxisLessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.Long-Acting Antiretrovirals: Where Are We now?A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis.Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.Antiretroviral pre-exposure prophylaxis preferences among men who have sex with men in Vietnam: results from a nationwide cross-sectional survey.Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.Facilitators and Barriers to Pre-Exposure Prophylaxis Willingness Among Young Men Who Have Sex with Men Who Use Geosocial Networking Applications in California.The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature.MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication.Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.Awareness of Prevention Strategies and Willingness to Use Preexposure Prophylaxis in Brazilian Men Who Have Sex With Men Using Apps for Sexual Encounters: Online Cross-Sectional Study.Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?Acceptability of Injectable and On-Demand Pre-Exposure Prophylaxis Among an Online Sample of Young Men Who Have Sex with Men in CaliforniaTo switch or not to switch: Intentions to switch to injectable PrEP among gay and bisexual men with at least twelve months oral PrEP experienceUltra-long-acting removable drug delivery system for HIV treatment and prevention
P2860
Q28550108-32BE1803-71DD-486C-AF02-86B6B948A1BDQ33446435-8BE5E30C-9396-4DAC-8CFD-D1181F887168Q33447623-8A094630-C375-447A-BC85-1308CF5D19BBQ35541521-C909787F-B475-4176-9BA4-EE05F95FBE94Q38613878-08790C9B-443F-4A85-B113-A6D5BB75DA24Q38615185-EFF04388-7EC7-49D1-8C9C-D66509C0E78FQ38651723-0E4FC580-EC90-4616-B663-F5A2809C6938Q38902077-B854647D-B639-497C-A704-F3853AFC4241Q39125456-14F747CB-B357-437D-85F2-C7095A324B2EQ39371494-6903FB8A-CA85-4A84-A19B-77B9C7415DB6Q39573866-AA884C41-1D47-4A8A-94FC-5598849DB01EQ40135129-AE8C8443-86F5-4E80-8C66-379153A565BAQ41996235-2674D1D3-2E0F-4306-816E-A616982C5A7CQ46535667-40F2B314-A6B4-4F00-A8EF-B9D73DC48AD9Q47236110-881AF9CC-2DC0-4548-836E-F379DB5C8F82Q47621369-C0470060-04EF-40A0-81FB-BC141C240238Q48101425-9C6B1604-4379-44C6-9757-8D752DFB842EQ48192005-F9CB473E-F91E-4524-96A6-7BDD37A400F4Q48342302-F5D5859C-F0E0-4710-80BC-5EF6594B3C58Q49382513-DBE6FF8F-24D7-46AA-A389-650F74516D0BQ50075573-758D86D8-593A-4347-96C9-9BB850E5AA0EQ57173053-3FB7EE17-4A96-4871-86A2-C11042857252Q57175401-DEE33661-2661-428B-BC76-0E37EDC335BEQ57295387-42AE184C-CC4C-4E6F-9947-9C6C93AE769C
P2860
High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@ast
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@en
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@nl
type
label
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@ast
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@en
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@nl
prefLabel
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@ast
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@en
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@nl
P2093
P2860
P1433
P1476
High interest in a long-acting ...... in NYC: a P18 cohort substudy
@en
P2093
Ilana Gratch
Kathrine Meyers
Kristina Rodriguez
Martin Markowitz
Perry N Halkitis
P2860
P304
P356
10.1371/JOURNAL.PONE.0114700
P407
P577
2014-12-11T00:00:00Z